BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GE Capital Provides $10 Million Term Loan Facility to InfraReDx


12/5/2011 7:22:14 AM

BETHESDA, Md., Dec 05, 2011 (BUSINESS WIRE) -- GE Capital, Healthcare Financial Services announced today that it was the sole lender on a $10 million senior secured multi-draw term loan to InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases. The financing will be used to help support product commercialization efforts.

"We've worked with GE Capital in the past so they are highly knowledgeable about our business and industry," said Donald Southard, president and chief executive officer, InfraReDx. "This expertise was essential in structuring a financing solution commensurate with the company's immediate and longer term growth objectives."

Based in Burlington, MA, InfraReDx develops intelligent imaging technologies to advance the diagnosis and treatment of coronary heart disease. The company's TVC Imaging System(TM) is a first-in-class intravascular imaging system providing information critical for evaluating vessel structure and chemical composition, helping to more fully characterize a vessel. It is the only multimodality imaging system to combine both intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS). The TVC Imaging System is the only device cleared by the U.S. Food and Drug Administration for the detection of lipid core plaques of interest, which are known to complicate stenting and are believed to cause the majority of heart attacks.

"We support healthcare innovation through the credit facilities we provide to promising young companies like InfraReDx," said Anthony Storino, senior managing director, GE Capital, Healthcare Financial Services, Life Sciences. "The capital we provide helps our customers to invest and grow."

About GE Capital, Healthcare Financial Services

With in-depth industry knowledge and expertise, GE Capital, Healthcare Financial Services has provided more than $60 billion in financing to companies in over 40 healthcare sub-sectors including senior housing, hospitals, medical offices, outpatient services, pharmaceuticals and medical devices. Our team of professionals creates business and financial solutions tailored to meet the individual needs of our customers. For more information, visit gecapital.com/healthcare.

GE Capital offers consumers and businesses around the globe an array of financial products and services. For more information, visit gecapital.com or follow company news via Twitter (@GECapital). GE /quotes/zigman/227468/quotes/nls/ge GE +1.96% is a diversified infrastructure, finance and media company taking on the world's toughest challenges. Visit ge.com.

SOURCE: GE Capital

GE Capital, Americas

Ned Reynolds, 203-229-5717

ned.reynolds@ge.com

or

GE Capital, Healthcare Financial Services

Jeanne DeLeonardo, 203-229-5244

jeanne.deleonardo@ge.com



Read at BioSpace.com
Read at Mass High Tech

InfraReDx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->